SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Novo Nordisk CSO: We Believe Nextgen GLP-1 To Be Potentially Differentiated Across Efficacy, Convenience, Safety, Tolerability